$0.25
0.00 (-1.64%)
Open$0.27
Previous Close$0.26
Day High$0.27
Day Low$0.25
52W High$11.80
52W Low$0.23
Volume—
Avg Volume58.7K
Market Cap114.11M
P/E Ratio—
EPS$-0.13
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 152.21M | 182.03M | 106.35M |
| Net Income | -80,062,146 | -86,170,690 | 12.42M |
| Profit Margin | -52.6% | -50.0% | 11.7% |
| EBITDA | -44,645,671 | -50,721,582 | 22.69M |
| Free Cash Flow | — | — | 8.29M |
| Rev Growth | -16.4% | -16.4% | +7.5% |
| Debt/Equity | 0.00 | 0.00 | 0.19 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |